NO960175D0 - Redirigering av cellulær immunitet med reseptor-chimeras - Google Patents

Redirigering av cellulær immunitet med reseptor-chimeras

Info

Publication number
NO960175D0
NO960175D0 NO960175A NO960175A NO960175D0 NO 960175 D0 NO960175 D0 NO 960175D0 NO 960175 A NO960175 A NO 960175A NO 960175 A NO960175 A NO 960175A NO 960175 D0 NO960175 D0 NO 960175D0
Authority
NO
Norway
Prior art keywords
cell
receptor
infective agent
chimeric
redirection
Prior art date
Application number
NO960175A
Other languages
English (en)
Other versions
NO316942B1 (no
NO960175L (no
Inventor
Brian Seed
Charles Romeo
Waldemar Kolanus
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO960175D0 publication Critical patent/NO960175D0/no
Publication of NO960175L publication Critical patent/NO960175L/no
Publication of NO316942B1 publication Critical patent/NO316942B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19960175A 1993-07-16 1996-01-15 Celle uttrykkende kimert reseptorprotein, samt DNA og vektor NO316942B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9321093A 1993-07-16 1993-07-16
PCT/US1994/006675 WO1995002686A1 (en) 1993-07-16 1994-06-14 Redirection of cellular immunity by receptor chimeras

Publications (3)

Publication Number Publication Date
NO960175D0 true NO960175D0 (no) 1996-01-15
NO960175L NO960175L (no) 1996-03-15
NO316942B1 NO316942B1 (no) 2004-07-05

Family

ID=22237762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19960175A NO316942B1 (no) 1993-07-16 1996-01-15 Celle uttrykkende kimert reseptorprotein, samt DNA og vektor

Country Status (18)

Country Link
EP (1) EP0804552B1 (no)
JP (2) JP3588115B2 (no)
KR (1) KR100278352B1 (no)
AT (1) ATE236973T1 (no)
AU (2) AU686646B2 (no)
CA (1) CA2166102C (no)
CZ (1) CZ291754B6 (no)
DE (1) DE69432487T2 (no)
DK (1) DK0804552T3 (no)
ES (1) ES2197166T3 (no)
FI (1) FI119995B (no)
HU (1) HU224137B1 (no)
NO (1) NO316942B1 (no)
NZ (1) NZ269312A (no)
PT (1) PT804552E (no)
RU (1) RU2158305C2 (no)
WO (1) WO1995002686A1 (no)
ZA (1) ZA945204B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US6407221B1 (en) 1990-12-14 2002-06-18 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5851828A (en) 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5837544A (en) * 1995-02-02 1998-11-17 Cell Genesys, Inc. Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
US6103521A (en) * 1995-02-06 2000-08-15 Cell Genesys, Inc. Multispecific chimeric receptors
GB9526131D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Recombinant chimeric receptors
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
US5916771A (en) * 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
GB9809658D0 (en) * 1998-05-06 1998-07-01 Celltech Therapeutics Ltd Biological products
US20130310387A1 (en) 2012-05-16 2013-11-21 Novartis Ag Monocyclic Heteroaryl Cycloalkyldiamine Derivatives
CA3093078A1 (en) 2018-03-06 2019-09-12 The Trustees Of The University Of Pennsylvania Prostate-specific membrane antigen cars and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
IL101147A (en) * 1991-03-07 2004-06-20 Gen Hospital Corp Change of direction of cellular immunity by chimera receptors

Also Published As

Publication number Publication date
EP0804552A4 (en) 1999-07-14
CA2166102A1 (en) 1995-01-26
FI960178A (fi) 1996-01-15
FI960178A0 (fi) 1996-01-15
KR100278352B1 (ko) 2001-01-15
HU224137B1 (hu) 2005-05-30
HUT74252A (en) 1996-11-28
WO1995002686A1 (en) 1995-01-26
RU2158305C2 (ru) 2000-10-27
NZ269312A (en) 1998-02-26
CA2166102C (en) 2008-03-18
PT804552E (pt) 2003-08-29
AU712245C (en) 2004-10-28
NO316942B1 (no) 2004-07-05
ES2197166T3 (es) 2004-01-01
EP0804552A1 (en) 1997-11-05
AU7314094A (en) 1995-02-13
CZ291754B6 (cs) 2003-05-14
ZA945204B (en) 1995-05-30
JP2004222735A (ja) 2004-08-12
DE69432487T2 (de) 2004-04-08
NO960175L (no) 1996-03-15
DK0804552T3 (da) 2003-07-28
AU6476798A (en) 1998-07-02
AU712245B2 (en) 1999-11-04
FI119995B (fi) 2009-05-29
JP3738024B2 (ja) 2006-01-25
HU9600084D0 (en) 1996-03-28
CZ340895A3 (en) 1996-08-14
ATE236973T1 (de) 2003-04-15
AU686646B2 (en) 1998-02-12
JP3588115B2 (ja) 2004-11-10
EP0804552B1 (en) 2003-04-09
JPH09500020A (ja) 1997-01-07
DE69432487D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
FI973466A (fi) Soluimmuniteetin suuntaaminen uudelleen proteiinityrosiinikinaasikimeerojen avulla
ZA961477B (en) Redirection of cellular immunity by receptor chimeras.
MX9201002A (es) Redireccion de inmunidad celular mediante quimeras receptoras.
NO960175L (no) Redirigering av cellulær immunitet med reseptor-chimeras

Legal Events

Date Code Title Description
MK1K Patent expired